<--- Back to Details
First PageDocument Content
Ketones / Opioid receptor / Vesicoureteral reflux / Opioid / Urinary tract infection / Methotrexate / Trimethoprim / Tofacitinib / Methadone / Chemistry / Medicine / Organic chemistry
Date: 2014-06-21 10:19:28
Ketones
Opioid receptor
Vesicoureteral reflux
Opioid
Urinary tract infection
Methotrexate
Trimethoprim
Tofacitinib
Methadone
Chemistry
Medicine
Organic chemistry

Dear friends of clinical journal club: The N Engl J Med image of the week shows a lower leg with a scaly lichen-like rash. You are offered asteatoic eczema, chronic venous stasis, necrobiosis lipoidica, pretibial myxedem

Add to Reading List

Source URL: www.charite-buch.de

Download Document from Source Website

File Size: 67,88 KB

Share Document on Facebook

Similar Documents

------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

DocID: 1m0Le - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.   Dermatological toxicity: Interr

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.  Dermatological toxicity: Interr

DocID: 1lmpL - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT.  gastrointestinal perforation or

HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. gastrointestinal perforation or

DocID: 1lep2 - View Document

Tofacitinib for chronic plaque psoriasis – second line

Tofacitinib for chronic plaque psoriasis – second line

DocID: 1dvG6 - View Document

542  CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials

542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials

DocID: 1anTs - View Document